Brazil's Anvisa Notifies Mercado Livre Over Prescription Drug Sales

Brazil's health regulator Anvisa has formally notified Mercado Livre after the marketplace announced it would mediate sales of prescription medicines, questioning the legal basis for such operations. Anvisa requests information on the regularity of the sales, signaling potential regulatory action. This could set a precedent for e-commerce platforms in Brazil's pharmaceutical sector.